BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 35803962)

  • 1. PRMT5 activates AKT via methylation to promote tumor metastasis.
    Huang L; Zhang XO; Rozen EJ; Sun X; Sallis B; Verdejo-Torres O; Wigglesworth K; Moon D; Huang T; Cavaretta JP; Wang G; Zhang L; Shohet JM; Lee MM; Wu Q
    Nat Commun; 2022 Jul; 13(1):3955. PubMed ID: 35803962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PRMT5-mediated arginine methylation activates AKT kinase to govern tumorigenesis.
    Yin S; Liu L; Brobbey C; Palanisamy V; Ball LE; Olsen SK; Ostrowski MC; Gan W
    Nat Commun; 2021 Jun; 12(1):3444. PubMed ID: 34103528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein arginine methyltransferase 5 (PRMT5) promotes survival of lymphoma cells via activation of WNT/β-catenin and AKT/GSK3β proliferative signaling.
    Chung J; Karkhanis V; Baiocchi RA; Sif S
    J Biol Chem; 2019 May; 294(19):7692-7710. PubMed ID: 30885941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PRMT5-mediated histone arginine methylation antagonizes transcriptional repression by polycomb complex PRC2.
    Liu F; Xu Y; Lu X; Hamard PJ; Karl DL; Man N; Mookhtiar AK; Martinez C; Lossos IS; Sun J; Nimer SD
    Nucleic Acids Res; 2020 Apr; 48(6):2956-2968. PubMed ID: 32025719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An AKT/PRMT5/SREBP1 axis in lung adenocarcinoma regulates de novo lipogenesis and tumor growth.
    Liu L; Yan H; Ruan M; Yang H; Wang L; Lei B; Sun X; Chang C; Huang G; Xie W
    Cancer Sci; 2021 Aug; 112(8):3083-3098. PubMed ID: 34033176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-talk between Arg methylation and Ser phosphorylation modulates apoptosis signal-regulating kinase 1 activation in endothelial cells.
    Chen M; Qu X; Zhang Z; Wu H; Qin X; Li F; Liu Z; Tian L; Miao J; Shu W
    Mol Biol Cell; 2016 Apr; 27(8):1358-66. PubMed ID: 26912789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PRMT5 promotes epithelial-mesenchymal transition via EGFR-β-catenin axis in pancreatic cancer cells.
    Ge L; Wang H; Xu X; Zhou Z; He J; Peng W; Du F; Zhang Y; Gong A; Xu M
    J Cell Mol Med; 2020 Jan; 24(2):1969-1979. PubMed ID: 31851779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting protein arginine methyltransferase 5 inhibits colorectal cancer growth by decreasing arginine methylation of eIF4E and FGFR3.
    Zhang B; Dong S; Zhu R; Hu C; Hou J; Li Y; Zhao Q; Shao X; Bu Q; Li H; Wu Y; Cen X; Zhao Y
    Oncotarget; 2015 Sep; 6(26):22799-811. PubMed ID: 26078354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting PRMT5/Akt signalling axis prevents human lung cancer cell growth.
    Zhang S; Ma Y; Hu X; Zheng Y; Chen X
    J Cell Mol Med; 2019 Feb; 23(2):1333-1342. PubMed ID: 30461193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PRMT5 facilitates angiogenesis and EMT via HIF-1α/VEGFR/Akt signaling axis in lung cancer.
    Zheng Y; Ji H; Yi W; Chen Z; Hu X; Zhou J; Wang Y; Zheng X
    Aging (Albany NY); 2023 Jul; 15(13):6163-6178. PubMed ID: 37400960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PRMT5/FGFR3/AKT Signaling Axis Facilitates Lung Cancer Cell Metastasis.
    Zheng Y; Lu J; Hu X; Hu X; Gao X; Zhou J
    Technol Cancer Res Treat; 2023; 22():15330338231161139. PubMed ID: 36927233
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of PRMT5/MEP50 Arginine Methyltransferase Activity Causes Cancer Vulnerability in NDRG2
    Ichikawa T; Suekane A; Nakahata S; Iha H; Shimoda K; Murakami T; Morishita K
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A TGFβ-PRMT5-MEP50 axis regulates cancer cell invasion through histone H3 and H4 arginine methylation coupled transcriptional activation and repression.
    Chen H; Lorton B; Gupta V; Shechter D
    Oncogene; 2017 Jan; 36(3):373-386. PubMed ID: 27270440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein arginine methyltransferase 5 is a potential oncoprotein that upregulates G1 cyclins/cyclin-dependent kinases and the phosphoinositide 3-kinase/AKT signaling cascade.
    Wei TY; Juan CC; Hisa JY; Su LJ; Lee YC; Chou HY; Chen JM; Wu YC; Chiu SC; Hsu CP; Liu KL; Yu CT
    Cancer Sci; 2012 Sep; 103(9):1640-50. PubMed ID: 22726390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PRMT5 Promotes EMT Through Regulating Akt Activity in Human Lung Cancer.
    Huang J; Zheng Y; Zheng X; Qian B; Yin Q; Lu J; Lei H
    Cell Transplant; 2021; 30():9636897211001772. PubMed ID: 33829865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myosin phosphatase and RhoA-activated kinase modulate arginine methylation by the regulation of protein arginine methyltransferase 5 in hepatocellular carcinoma cells.
    Sipos A; Iván J; Bécsi B; Darula Z; Tamás I; Horváth D; Medzihradszky KF; Erdődi F; Lontay B
    Sci Rep; 2017 Jan; 7():40590. PubMed ID: 28074910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PRMT5 orchestrates EGFR and AKT networks to activate NFκB and promote EMT.
    Huang L; Ravi M; Zhang XO; Verdejo-Torres O; Shendy NAM; Nezhady MAM; Gopalan S; Wang G; Durbin AD; Fazzio TG; Wu Q
    bioRxiv; 2024 Jan; ():. PubMed ID: 38260418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRMT5 is upregulated by B-cell receptor signaling and forms a positive-feedback loop with PI3K/AKT in lymphoma cells.
    Zhu F; Guo H; Bates PD; Zhang S; Zhang H; Nomie KJ; Li Y; Lu L; Seibold KR; Wang F; Rumball I; Cameron H; Hoang NM; Yang DT; Xu W; Zhang L; Wang M; Capitini CM; Rui L
    Leukemia; 2019 Dec; 33(12):2898-2911. PubMed ID: 31123343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PRMT5 Enables Robust STAT3 Activation via Arginine Symmetric Dimethylation of SMAD7.
    Cai C; Gu S; Yu Y; Zhu Y; Zhang H; Yuan B; Shen L; Yang B; Feng XH
    Adv Sci (Weinh); 2021 May; 8(10):2003047. PubMed ID: 34026434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arginine methyltransferase PRMT5 methylates and stabilizes KLF5 via decreasing its phosphorylation and ubiquitination to promote basal-like breast cancer.
    Wang X; Qiu T; Wu Y; Yang C; Li Y; Du G; He Y; Liu W; Liu R; Chen CH; Shi Y; Pan J; Zhou J; Jiang D; Chen C
    Cell Death Differ; 2021 Oct; 28(10):2931-2945. PubMed ID: 33972717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.